Skip to main content

Animations

MJFF Publications

3101 - 3110 of 8808 Results
Title
Year
  • Year
  • 2016
  • 2020
  • 2008
  • 2018
  • 2022
  • 2020
  • 2022
  • 2020
  • 2023
  • 2019
  • Summary Details
    OPEN
    Title: A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1186/s13024-016-0125-0
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100042
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2008.09.003
    Citation Count: 240
  • Summary Details
    OPEN
    Title: A comprehensive screening of copy number variability in dementia with Lewy bodies
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29058
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Remote Digital Monitoring for Medical Product Development
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cts.12851
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
    Journal Name: Molecular Therapy - Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007
    Citation Count: 21
  • Summary Details
    OPEN
    Title: ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1922342117
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awz260
    Citation Count: 85
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.